Olfactory ensheathing cell grafts have minimal influence on regeneration at the dorsal root entry zone following rhizotomy.
The effectiveness of grafts of olfactory ensheathing cells (OECs) as a means of promoting functional reconnection of regenerating primary afferent fibers was investigated following dorsal root injury. Adult rats were subjected to dorsal root section and reanastomosis and at the same operation a suspension of purified OECs was injected at the dorsal root entry zone and/or into the sectioned dorsal root. Regeneration of dorsal root fibers was then assessed after a survival period ranging from 1 to 6 months. In 11 animals, electrophysiology was used to look for evidence of functional reconnection of regenerating dorsal root fibers. However, electrical stimulation of lesioned dorsal roots failed to evoke detectable cord dorsum or field potentials within the spinal cord of any of the animals examined, indicating that reconnection of regenerating fibers with spinal cord neurones had not occurred. In a further 11 rats, immunocytochemical labeling and biotin dextran tracing of afferent fibers in the lesioned roots was used to determine whether regenerating fibers were able to grow into the spinal cord in the presence of an OEC graft. Although a few afferent fibers could be seen to extend for a limited distance into the spinal cord, similar minimal in-growth was seen in control animals that had not been injected with OECs. We therefore conclude that OEC grafts are of little or no advantage in promoting the in-growth of regenerating afferent fibers at the dorsal root entry zone following rhizotomy.
Riddell
John S
JS
Division of Neuroscience and Biomedical Systems, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, UK. j.riddell@bio.gla.ac.uk
Enriquez-Denton
Manuel
M
Toft
Andrew
A
Fairless
Richard
R
Barnett
Susan C
SC
D000200:Action Potentials / Q000502:physiology; D000344:Afferent Pathways / Q000166:cytology / Q000254:growth & development / Q000293:injuries; D000818:Animals; D000831:Animals, Newborn; D001710:Biotin / Q000031:analogs & derivatives*; D016380:Brain Tissue Transplantation / Q000379:methods* / Q000639:trends; D002478:Cells, Cultured; D003714:Denervation; D003911:Dextrans; D004558:Electric Stimulation; D020439:Growth Cones / Q000502:physiology / Q000648:ultrastructure; D009416:Nerve Regeneration / Q000502:physiology*; D009431:Neural Conduction / Q000502:physiology; D016900:Neurofilament Proteins / Q000378:metabolism; D009457:Neuroglia / Q000166:cytology / Q000502:physiology / Q000637:transplantation*; D009475:Neurons, Afferent / Q000166:cytology / Q000502:physiology; D009830:Olfactory Bulb / Q000166:cytology / Q000502:physiology / Q000637:transplantation*; D011843:Radiculopathy / Q000503:physiopathology / Q000628:therapy*; D051381:Rats; D011916:Rats, Inbred F344; D020127:Recovery of Function / Q000502:physiology; D019051:Rhizotomy; D013126:Spinal Nerve Roots / Q000166:cytology / Q000293:injuries / Q000503:physiopathology*; D016896:Treatment Outcome
D003911:Dextrans; D016900:Neurofilament Proteins; C076397:biotinylated dextran amine; D001710:Biotin